Are Double-ring Wound-edge Protectors Effective for Preventing Superficial Surgical Site Infection After Open Appendectomy?
NCT ID: NCT04860570
Last Updated: 2023-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
671 participants
OBSERVATIONAL
2024-10-25
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main objective of the study is to compare the incidence of superficial surgical site infection in both groups.
All patients included in the study must meet inclusion criteria and all data will be collected anonymously in order to comply with local law on personal data protection (Organic Law 15/1999 from 13 December about personal data protection).
The authors of the study expect results of the study to be comparable with those in current literature regarding surgical site infections, hospital stay and procedure safety.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open Appendectomy (OA) + Double-ring wound-edge protector (2RWEP)
Intervention group: Patients with diagnosis of acute appendicitis treated by open appendectomy using a double-ring wound-edge protector.
Double-ring wound-edge protector
Double-ring wound-edge protector: Alexis Applied Medical ®, Rancho Santa Margarita, California.
Laparoscopic Appendectomy (LA)
Control group: Patients with diagnosis of acute appendicitis treated by laparoscopic appendectomy.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Double-ring wound-edge protector
Double-ring wound-edge protector: Alexis Applied Medical ®, Rancho Santa Margarita, California.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical diagnosis of acute appendicitis.
* Treated by: Open appendectomy + double-ring wound-edge protector or Laparoscopic appendectomy.
* Note: with the aim of avoiding selection bias, all patients presenting risk factors for surgical site infections (eg obesity, diabetes, malnourishment, immunosupression, etc.) will be included in the present study.
Exclusion Criteria
* Source of abdominal pathology other than the caecal appendix.
* Follow-up period less than 30 days.
15 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Medina del Campo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Johnn Henry Herrera Kok
Dr. Johnn Henry Herrera Kok
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johnn Henry Herrera Kok
Role: PRINCIPAL_INVESTIGATOR
Complejo Asistencial Universitario de León, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Comarcal de Medina del Campo
Medina del Campo, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Johnn Henry Herrera Kok, MD
Role: primary
Juan Carlos Martín Del Olmo, MD, phD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI 21-2140 MEDINA
Identifier Type: -
Identifier Source: org_study_id